Myriad Genetics

Type	Public
Founded	Salt Lake City, Utah, USA (1992)
Headquarters	Salt Lake City, Utah, USA
Key people	Walter Gilbert, Co-Founder, Director, and Vice Chair
Industry	Health Care biopharmaceutical biotech
Website	www.myriad.com

Myriad Genetics is a biopharmaceutical company head-quartered in the University of Utah Research Park in Salt Lake City, Utah. It was co-founded in 1991 by Mark Skolnick and Nobel laureate Dr. Walter Gilbert.^[1] The company markets cancer predictive medicine products and develops therapeutics including drug candidates in the areas of Alzheimer's disease and cancer.

Contents 1 Public and Corporate Appeal 2 See also 3 References 4 External links

[edit] Public and Corporate Appeal

Myriad Genetics has been referred to as "probably the most hated diagnostics company" for its refusal to license its products to any other company.^[2] Lawyers at the ACLU serve as counsel for the plaintiffs in a lawsuit against Myriad Genetics. In the suit, medical associations, doctors, and patients are suing Myriad Genetics for its United States patents on genes related to breast cancer and ovarian cancer.^[3] The defendants' motions to dismiss were denied on November 1, 2009.^[4]

[edit] See also

• Gene patents

[edit] References

[edit] External links

• Myriad Genetics home page
• Court documents for ACLU suit

This United States corporation or company article is a stub. You can help Wikipedia by expanding it. v • d • e